Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
patent settlements
Pharma
Takeda, Daiichi Sankyo, Dizal, Biden and more—Fierce Pharma Asia
Takeda pours €300M into plasma-derived therapies production. Daiichi and AZ spinout Dizal reveal promising lung cancer data.
Angus Liu
Sep 16, 2022 10:15am
AZ-Daiichi, Biogen-Eisai, Hutchmed, Junshi—Fierce Pharma Asia
May 6, 2022 11:35am
AstraZeneca pays Roche $775M to settle Ultomiris patent brawl
Mar 17, 2022 9:40am
Roche, AstraZeneca settle Ultomiris patent lawsuit
Feb 18, 2022 10:54am
BMS-Eisai, China price cuts, AZ-Hutchmed—Fierce Pharma Asia
Jun 25, 2021 10:50am
Sun Pharma has clinched a deal to market its Revlimid generic
Jun 22, 2021 11:10am
